keyword
https://read.qxmd.com/read/38635872/fucoidan-improves-early-stage-diabetic-nephropathy-via-the-gut-microbiota-mitochondria-axis-in-high-fat-diet-induced-diabetic-mice
#1
JOURNAL ARTICLE
Zhaoyi Zhong, Yangting Zhang, Yuan Wei, Xiaona Li, Lisheng Ren, Yan Li, Xueqian Zhang, Chengyu Chen, Xueru Yin, Run Liu, Qiuzhen Wang
Diabetic nephropathy (DN) is a common microvascular complication of diabetes. Fucoidan, a polysaccharide containing fucose and sulfate group, ameliorates DN. However, the underlying mechanism has not been fully understood. This study aimed to explore the effects and mechanism of fucoidan on DN in high-fat diet-induced diabetic mice. A total of 90 C57BL/6J mice were randomly assigned to six groups ( n = 15) as follows: normal control (NC), diabetes mellitus (DM), metformin (MTF), low-dose fucoidan (LFC), medium-dose fucoidan (MFC), and high-dose fucoidan (HFC)...
April 18, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38634619/theaflavin-3-3-digallate-protects-liver-and-kidney-functions-in-diabetic-rats-by-up-regulating-circ-itch-and-nrf2-signaling-pathway
#2
JOURNAL ARTICLE
Hongjuan Fu, Jianbo He, Cong Li, Chang Hui
Theaflavin-3,3'-digallate (TFDG) in black tea has a strong antioxidant capacity. However, its effect on diabetic liver and kidney injury and the underlying mechanisms remain unclear. In the present study, our findings indicated that TFDG administration effectively lowers the fasting blood glucose and serum lipid concentrations and enhances the functionality and cellular architecture of the liver and kidney in rats with diabetes. The data also showed that TFDG mitigates oxidative harm in the liver and kidney of rats afflicted with diabetes...
April 18, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38633552/covid-19-an-update-on-epidemiology-prevention-and-treatment-september-2023
#3
REVIEW
Serap Şimşek-Yavuz
After a downward trend for more than 12 months, the incidence of COVID-19 has increased in the last months. Although COVID-19 is not as frequent as in the first years of the pandemic, case numbers are still very high, and it causes a significant number of deaths. COVID-19 is not seen with a predictable frequency, at least two times more deadly than the flu, continues as an epidemic, and has not reached the endemic level yet. Currently, the Omicron strains EG.5 and XBB.1.16 are dominant worldwide. Although BA...
September 2023: Infect Dis Clin Microbiol
https://read.qxmd.com/read/38631826/aspirin-versus-metformin-in-pregnancies-at-high-risk-of-preterm-pre-eclampsia-in-china-avert-protocol-for-a-multicentre-double-blind-3-arm-randomised-controlled-trial
#4
JOURNAL ARTICLE
Jiao Liu, Lixia Shen, Long Nguyen-Hoang, Qiongjie Zhou, Chi Chiu Wang, Xiaohong Lu, Daljit Sahota, Ka Chun Chong, Hao Ying, Weirong Gu, Rong Zhou, Huixia Yang, Yanmin Jiang, Dunjin Chen, Xiaotian Li, Liona Poon
INTRODUCTION: Pre-eclampsia (PE) affects about 5% of Chinese pregnant women and is a major cause of maternal and perinatal morbidity and mortality. The first trimester screening model developed by the Fetal Medicine Foundation, which uses the Bayes theorem to combine maternal characteristics and medical history together with measurements of biomarkers, has been proven to be effective and has superior screening performance to that of the traditional risk factor-based approach for the prediction of PE...
April 17, 2024: BMJ Open
https://read.qxmd.com/read/38631189/biomarkers-of-frailty
#5
REVIEW
Mariam El Assar, Isabel Rodríguez-Sánchez, Alejandro Álvarez-Bustos, Leocadio Rodríguez-Mañas
Several biomarkers have been proposed to identify frailty, a multisystemic age-related syndrome. However, the complex pathophysiology and the absence of a consensus on a comprehensive and universal definition make it challenging to pinpoint a singular biomarker or set of biomarkers that conclusively characterize frailty. This review delves into the main laboratory biomarkers, placing special emphasis on those associated with various pathways closely tied to the frailty condition, such as inflammation, oxidative stress, mitochondrial dysfunction, metabolic and endocrine alterations and microRNA...
April 16, 2024: Molecular Aspects of Medicine
https://read.qxmd.com/read/38630483/laser-and-light-based-therapies-for-hirsutism-management-in-women-with-polycystic-ovarian-syndrome-a-systematic-review
#6
JOURNAL ARTICLE
Katrina Tan, Thisara Coster, Aya Mousa, Adrian Mar, Terhi Piltonen, Jacqueline A Boyle, Helena Teede, Anju Joham, Daniela Romualdi, Chau Thien Tay
IMPORTANCE: Hirsutism represents a significant concern for women with polycystic ovary syndrome (PCOS), with deleterious psychological effects warranting acknowledgment and a clear imperative to provide effective management. To our knowledge, this is the first review to exclusively examine the effectiveness of laser and light-based therapies in addressing hirsutism in women with PCOS. OBJECTIVE: To synthesize the existing literature regarding the effectiveness of laser and light hair reduction therapies, either as stand-alone treatments or in combination with systemic agents, in treating hirsutism for women with PCOS...
April 17, 2024: JAMA Dermatology
https://read.qxmd.com/read/38630424/the-gehan-test-identifies-life-extending-compounds-overlooked-by-the-log-rank-test-in-the-nia-interventions-testing-program-metformin-enalapril-caffeic-acid-phenethyl-ester-green-tea-extract-and-17-dimethylaminoethylamino-17-demethoxygeldanamycin-hydrochloride
#7
JOURNAL ARTICLE
Nisi Jiang, Jonathan Gelfond, Qianqian Liu, Randy Strong, James F Nelson
The National Institute on Aging Interventions Testing Program (ITP) has so far identified 12 compounds that extend the lifespan of genetically heterogeneous mice using the log-rank test. However, the log-rank test is relatively insensitive to any compound that does not uniformly reduce mortality across the lifespan. This test may thus miss compounds that only reduce mortality before midlife, for example, a plausible outcome if a compound only mitigates risk factors before midlife or if its efficacy is reduced at later ages...
April 17, 2024: GeroScience
https://read.qxmd.com/read/38627767/exosomes-biogenesis-was-increased-in-metformin-treated-human-ovary-cancer-cells-possibly-to-mediate-resistance
#8
JOURNAL ARTICLE
Reza Abbasi, Vahid Nejati, Jafar Rezaie
BACKGROUND: Exosomes derived from tumor cells contribute to the pathogenesis of cancers. Metformin, the most usually used drug for type 2 diabetes, has been frequently investigated for anticancer effects. Here, we examined whether metformin affects exosomes signaling in human ovary cancer cells in vitro. METHODS: Human ovary cancer cells, including A2780 and Skov3 cells, were treated with metformin for either 24-48 h. Cell viability and caspase-3 activity were determined by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) and colorimetric assays respectively...
April 16, 2024: Cancer Cell International
https://read.qxmd.com/read/38627464/ppar-agonists-as-add-on-treatment-with-metformin-in-management-of-type-2-diabetes-a-systematic-review-and-meta-analysis
#9
JOURNAL ARTICLE
Saif Alnuaimi, Tea Reljic, Fatima S Abdulla, Hamda Memon, Sarah Al-Ali, Teagen Smith, Fadila Serdarevic, Zelija Velija Asimi, Ambuj Kumar, Sabina Semiz
The combination of metformin and the peroxisome proliferator-activated receptors (PPAR) agonists offers a promising avenue for managing type 2 diabetes (T2D) through their potential complementary mechanisms of action. The results from randomized controlled trials (RCT) assessing the efficacy of PPAR agonists plus metformin versus metformin alone in T2D are inconsistent, which prompted the conduct of the systematic review and meta-analysis. We searched MEDLINE and EMBASE from inception (1966) to March 2023 to identify all RCTs comparing any PPAR agonists plus metformin versus metformin alone in T2D...
April 16, 2024: Scientific Reports
https://read.qxmd.com/read/38626845/novel-drug-drug-salt-crystals-of-metformin-with-ibuprofen-or-naproxen-improved-solubility-dissolution-rate-and-synergistic-antinociceptive-effects
#10
JOURNAL ARTICLE
Hui-Min Qin, Zheng-Kang Luo, Hui-Ling Zhou, Jin Zhu, Xin-Yi Xiao, Yang Xiao, Tao Zhuang, Gui-Sen Zhang
As the monotherapy of available analgesics is usually accompanied by serious side effects or limited efficacy in the management of chronic pain, multimodal analgesia is widely used to achieve improved benefit-to-risk ratios in clinic Drug-drug salts are extensively researched to optimize the physicochemical properties of active pharmaceutical ingredients (APIs) and achieve clinical benefits compared with individual APIs or their combination. New drug-drug salt crystals metformin-ibuprofen (MET-IBU) and metformin-naproxen (MET-NAP) were prepared from metformin (MET) and two poorly water-soluble anti-inflammatory drugs (IBU and NAP) by the solvent evaporation method...
April 14, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38623534/metformin-associated-vitamin-b12-deficiency-an-underrecognized-complication
#11
Yotsapon Thewjitcharoen, Peachaphol Chongvoranond, Soontaree Nakasatien, Sirinate Krittiyawong, Thep Himathongkam
Metformin-associated vitamin B12 deficiency is a well-established side effect, especially in patients taking higher doses of metformin or who have existing risk factors. Severe deficiency causes a wide range of systemic disorders. Gait instability, which leads to frequent falling, is usually an underrecognized side effect. Older patients are more likely to develop chronic subdural hematoma even with minor trauma. We present a case of 84-year-old man with type 2 diabetes mellitus with acute-on-chronic subdural hematoma from frequent falls...
April 2024: JCEM Case Rep
https://read.qxmd.com/read/38621943/-effect-of-zuogui-jiangtang-qinggan-formula-on-lipid-metabolism-in-db-db-mouse-model-of-type-2-diabetes-mellitus-complicated-with-non-alcoholic-fatty-liver-disease
#12
JOURNAL ARTICLE
Min Zhou, Liu Li, Jun-Ju Zou, Xiu Liu, Yong-Jun Wu, Qin Xiang, Rong Yu
This study aims to explore the effect of Zuogui Jiangtang Qinggan Formula(ZGJTQGF) on the lipid metabolism in the db/db mouse model of type 2 diabetes mellitus(T2DM) complicated with non-alcoholic fatty liver disease(NAFLD) via the insulin receptor(INSR)/adenosine 5'-monophosphate(AMP)-activated protein kinase(AMPK)/sterol-regulatory element-binding protein 2(SREBP-2) signaling pathway. Twenty-four db/db mice were randomized into positive drug(metformin, 0.067 g·kg~(-1)) and low-(7.5 g·kg~(-1)) and high-dose(15 g·kg~(-1)) ZGJTQGF groups...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38621802/weight-management-with-orlistat-in-type-2-diabetes-an-electronic-healthcare-records-study
#13
JOURNAL ARTICLE
Shraboni Ghosal, Neil Heron, Kayleigh Mason, James Bailey, Kelvin Jordan
AIMS: Orlistat is recommended as an adjunct to diet and exercise for weight loss in type 2 diabetes mellitus (T2DM). The aims were to explore (i) associations between patient characteristics and orlistat prescribing and to determine (ii) associations of orlistat with weight loss in T2DM/prediabetes. METHODS: This cohort study used anonymised records of T2DM/prediabetes (2016-2017) patients ≥18 years, from the UK Clinical Practice Research Datalink (CPRD) database...
April 15, 2024: British Journal of General Practice
https://read.qxmd.com/read/38621769/metformin-ameliorates-endometrial-thickness-in-a-rat-model-of-thin-endometrium
#14
JOURNAL ARTICLE
M Imran, Aditya Khandvilkar, Siddhanath Metkari, Geetanjali Sachdeva, Uddhav Chaudhari
Metformin, a well-established anti-diabetic drug, is also used in managing various other metabolic disorders including polycystic ovarian syndrome (PCOS). There are evidences to show that metformin improves endometrial functions in PCOS women. However, fewer studies have explored the direct effects of metformin on endometrium. Previous in vitro studies have shown that therapeutic serum concentrations of metformin enhance endometrial epithelial cell proliferation. The present study was undertaken to investigate in vivo effects of metformin on endometrial proliferation in a rat model of thin endometrium...
June 2024: Clinical and Experimental Pharmacology & Physiology
https://read.qxmd.com/read/38621621/interplay-between-lipid-dysregulation-and-ferroptosis-in-chondrocytes-and-the-targeted-therapy-effect-of-metformin-on-osteoarthritis
#15
JOURNAL ARTICLE
Zhi Zou, Wenhui Hu, Fei Kang, Zhonghua Xu, Yuheng Li, Jing Zhang, Jianmei Li, Yuan Zhang, Shiwu Dong
INTRODUCTION: Osteoarthritis (OA) is a devastating whole-joint disease affecting a large population worldwide; the role of lipid dysregulation in OA and mechanisms underlying targeted therapy effect of lipid-lowering metformin on OA remains poorly defined. OBJECTIVES: To investigate the effects of lipid dysregulation on OA progression and to explore lipid dysregulation-targeting OA treatment of metformin. METHODS: RNA-Seq data, biochemical, and histochemical assays in human and murine OA cartilage as well as primary chondrocytes were utilized to determine lipid dysregulation...
April 13, 2024: Journal of Advanced Research
https://read.qxmd.com/read/38619822/sodium-glucose-cotransporter-2-inhibitors-vs-sulfonylureas-for-gout-prevention-among-patients-with-type-2-diabetes-receiving-metformin
#16
JOURNAL ARTICLE
Natalie McCormick, Chio Yokose, Na Lu, Deborah J Wexler, J Antonio Aviña-Zubieta, Mary A De Vera, Rozalina G McCoy, Hyon K Choi
IMPORTANCE: Sodium-glucose cotransporter type 2 inhibitors (SGLT2i) are a revolutionary treatment for type 2 diabetes (T2D) with cardiovascular, kidney, and serum urate-lowering benefits. OBJECTIVE: To compare risk of incident gout and rate of recurrent flares between patients with T2D initiating SGLT2i vs sulfonylurea, most common second-line glucose-lowering therapy, when added to metformin monotherapy. DESIGN, SETTING, AND PARTICIPANTS: This sequential, propensity score-matched, new-user comparative effectiveness study using target trial emulation framework included adults with T2D receiving metformin monotherapy in a Canadian general population database from January 1, 2014, to June 30, 2022...
April 15, 2024: JAMA Internal Medicine
https://read.qxmd.com/read/38618970/combination-of-retagliptin-and-henagliflozin-as-add-on-therapy-to-metformin-in-patients-with-type-2-diabetes-inadequately-controlled-with-metformin-a-multicentre-randomized-double-blind-active-controlled-phase-3-trial
#17
JOURNAL ARTICLE
Yao Wang, Chengxia Jiang, Xiaolin Dong, Mingwei Chen, Qin Gu, Lihui Zhang, Yanqin Fu, Tianrong Pan, Yan Bi, Weihong Song, Jing Xu, WeiPing Lu, Xiaodong Sun, Zi Ye, Danli Zhang, Liang Peng, Xiang Lin, Wei Dai, Quanren Wang, Wenying Yang
AIM: This study assessed the efficacy and safety of co-administering retagliptin and henagliflozin versus individual agents at corresponding doses in patients with type 2 diabetes mellitus who were inadequately controlled with metformin. METHODS: This multicentre, phase 3 trial consisted of a 24-week, randomized, double-blind, active-controlled period. Patients with glycated haemoglobin (HbA1c) levels between 7.5% and 10.5% were randomized to receive once-daily retagliptin 100 mg (R100; n = 155), henagliflozin 5 mg (H5; n = 156), henagliflozin 10 mg (H10; n = 156), co-administered R100/H5 (n = 155), or R100/H10 (n = 156)...
April 15, 2024: Diabetes, Obesity & Metabolism
https://read.qxmd.com/read/38618243/enhancing-metformin-induced-tumor-metabolism-destruction-by-glucose-oxidase-for-triple-combination-therapy
#18
JOURNAL ARTICLE
Rangrang Fan, Linrui Cai, Hao Liu, Hongxu Chen, Caili Chen, Gang Guo, Jianguo Xu
Despite decades of laboratory and clinical trials, breast cancer remains the main cause of cancer-related disease burden in women. Considering the metabolism destruction effect of metformin (Met) and cancer cell starvation induced by glucose oxidase (GOx), after their efficient delivery to tumor sites, GOx and Met may consume a large amount of glucose and produce sufficient hydrogen peroxide in situ . Herein, a pH-responsive epigallocatechin gallate (EGCG)-conjugated low-molecular-weight chitosan (LC-EGCG, LE) nanoparticle (Met-GOx/Fe@LE NPs) was constructed...
March 2024: Journal of Pharmaceutical Analysis
https://read.qxmd.com/read/38617792/understanding-the-action-mechanisms-of-metformin-in-the-gastrointestinal-tract
#19
REVIEW
Meihui Cheng, Lili Ren, Xianxian Jia, Jianwei Wang, Bin Cong
Metformin is the initial medication recommended for the treatment of type 2 diabetes mellitus (T2DM). In addition to diabetes treatment, the function of metformin also can be anti-aging, antiviral, and anti-inflammatory. Nevertheless, further exploration is required to fully understand its mode of operation. Historically, the liver has been acknowledged as the main location where metformin reduces glucose levels, however, there is increasing evidence suggesting that the gastrointestinal tract also plays a significant role in its action...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38615625/metformin-improves-sarcopenia-related-quality-of-life-in-geriatric-adults-a-randomized-controlled-trial
#20
JOURNAL ARTICLE
Rizwan Qaisar, Asima Karim, Tahir Muhammad, M Shahid Iqbal, Firdos Ahmad
OBJECTIVES: Metformin protects against age-related muscle decline, termed sarcopenia. However, the effects on sarcopenia quality-of-life (SarQoL) are unknown. We investigated the effects of metformin on SarQoL and associated mechanisms in older adults. METHOD: This double-blind randomized, placebo-controlled trial included geriatric adult men, divided into non-sarcopenic controls (age = 72.2 ± 4.3 years, n = 52) and two groups of patients with sarcopenia randomized into placebo (age at baseline = 74...
April 13, 2024: Archives of Medical Research
keyword
keyword
113350
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.